[1]杜发旺.冠状动脉支架内血栓形成患者的危险因素及预后[J].介入放射学杂志,2016,(02):160-163.
　DU Fa- wang.Risk factors and prognosis of patients with coronary stent thrombosis [J].journal interventional radiology,2016,(02):160-163.
点击复制

冠状动脉支架内血栓形成患者的危险因素及预后 ()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2016年02期
页码:
160-163
栏目:
临床研究
出版日期:
2016-02-25

文章信息/Info

Title:
Risk factors and prognosis of patients with coronary stent thrombosis 
作者:
杜发旺
Author(s):
DU Fa- wang
Department of Cardiology， Guizhou Provincial People’s Hospital， Guiyang， Guizhou Province 550002， China
关键词:
【关键词】 冠状动脉疾病;  药物涂层支架;  支架内血栓;  危险因素
文献标志码:
A
摘要:
【摘要】 目的 分析冠状动脉药物涂层支架术后支架内血栓形成患者的危险因素及预后。方法 回顾性分析2006年7月到2012年3月冠脉支架内血栓形成的患者39例，并按1 ∶ 2配对抽取同期复查冠脉造影术未见支架内再狭窄患者78例，作为对照组从中分析术后支架内血栓形成的危险因素。结果 首发为急性心肌梗死、罪犯血管的支架直径及长度、术前左室射血分数（LVEF）低（<50%）与支架内血栓形成相关。选择再次行急症经皮冠脉介入术（PCI）者33例，1例术后在院内死亡，余32例好转出院。结论 首发为急性心肌梗死、植入罪犯血管支架的直径较小及长度较长、术前LVEF低（<50%）是支架血栓形成的独立危险因素。支架长度≥29.5 mm或支架直径≤2.94 mm与较高的支架内血栓的发生率相关。药物涂层支架术后发生支架内血栓的患者多表现为急性心肌梗死，发生支架内血栓后死亡率高，但早期行急症PCI是安全、有效的治疗。

参考文献/References:

［1］ Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus- eluting and paclitaxel- eluting stents in routine clinical practice: data from a large two- institutional cohort study［J］. Lancet, 2007, 369: 667- 678.
［2］ Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of siro- limus- and paclitaxel - eluting coronary stents［J］. N Engl J Med, 2007, 356: 998- 1008.
［3］ Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in ran- domized clinical trials of drug- eluting stents［J］. N Engl J Med, 2007, 356: 1020- 1029.
［4］ Lemesle G, De Labriolle A, Bonello L, et al. Clinical manifes- tation and prognosis of early versus late stent thrombosis of dru
-geluting stents［J］. J Interv Cardiol, 2009, 22: 228- 233.
［5］ Chechi T, Vecchio S, Vittori G, et al. ST- segment elevation myocardial infarction due to early and late stent thrombosis a new group of high- risk patients［J］. J Am Coll Cardiol, 2008, 51: 2396- 2402.
［6］ Ergelen M, Gorgulu S, Uyarel H, et al. The outcome of primary percutaneous coronary intervention for stent thrombosis causing ST- elevation myocardial infarction［J］. Am Heart J, 2010, 159: 672- 676.
［7］ Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions［J］. Circulation, 2007, 115: 2344- 2351.
［8］ de la Torre- Hernandez JM, Alfonso F, Hernandez F, et al. Drug
- eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA（Estudio Espanol sobre TROmbosis de stents FArmacoactivos）［J］. J Am Coll Cardiol, 2008, 51: 986- 990.
［9］ 潘春仰， 邱建平， 陆 林， 等． 冠状动脉介入治疗后支架内再狭窄相关因素［J］． 介入放射学杂志， 2015， 24： 467- 471．
［10］ Park KW, Hwang SJ, Kwon DA, et al. Characteristics and predictors of drug- eluting stent thrombosis: results from the multicenter ‘Korea Stent Thrombosis （KoST）’ registry［J］. Circ J, 2011, 75: 1626- 1632.
［11］ Suh J, Park DW, Lee JY, et al. The relationship and threshold of stent length with regard to risk of stent thrombosis after drug
-eluting stent implantation［J］. JACC Cardiovasc Interv, 2010, 3: 383- 389.
［12］ Ishigami K, Uemura S, Morikawa Y, et al. Long- term follow- up of neointimal coverage of sirolimus- eluting stents- evaluation with optical coherence tomography［J］. Circ J, 2009, 73: 2300- 2307.
［13］ Airoldi F, Colombo A, Morici N, et al. Incidence and predictors of drug- eluting stent thrombosis during and after discontinuation of thienopyridine treatment［J］. Circulation, 2007, 116: 745- 754.
［14］ Yong SA, Cho JH, Dong HK, et al. A fatal case of simultaneous,very late thrombosis involving three drug- eluting stents in three coronary arteries［J］. Korean Circ J, 2008, 38: 564- 569.
［15］ Buonamici P, Marcucci R, Migliorini A, et al. Impact of platelet reactivity after clopidogrel administration on drug- eluting stent thrombosis［J］. J Am Coll Cardiol, 2007, 49: 2312- 2317.
［16］ 韩雅玲， 徐 凯， 李 毅， 等． 150 mg高维持量氯吡格雷提高急性冠脉综合征患者药物洗脱支架植入术后的长期疗效［J］． 第三军医大学学报， 2008， 30： 435- 438．
［17］ CURRENT- OASIS 7 Investigators, Mehta SR, Bassand JP, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes［J］. N Engl J Med, 2010, 363: 930- 942.
［18］ Kang HJ, Clare RM, Gao R, et al. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: a retrospective analysis from the platelet inhibition and patient outcomes （PLATO） trial［J］. Am Heart J, 2015, 169: 899- 905.
［19］ 欧阳墉， 欧阳雪晖， 张学军， 等． 新一代药物洗脱支架及其抗血栓形成的作用［J］． 介入放射学杂志， 2014， 23： 369- 375．

相似文献/References:

[1]王 红. 紫杉醇涂层球囊治疗冠脉支架术后再狭窄的现状[J].介入放射学杂志,2012,(07):614.
　WANG Hong. The use of paclitaxel- coated balloon in the treatment of coronary in- stent restenosis： its current situation[J].journal interventional radiology,2012,(02):614.
[2]丁雪燕,刘夙璇,秦永文.冠状动脉西罗莫司洗脱支架植入术后晚期及超晚期支架内血栓形成的临床研究[J].介入放射学杂志,2012,(12):1023.
　DING Xue? yan,LIU Su? xuan,QIN Yong? wen..Late and extremely?蛳 late in?蛳 stent thrombosis formation after sirolimus?蛳 eluting stent implantation in coronary artery： a clinical study [J].journal interventional radiology,2012,(02):1023.
[3]吴志勇,关瑞锦,陈诗泉,等. 应用小直径旋磨头联合药物洗脱支架治疗冠状动脉重度钙化病变的疗效[J].介入放射学杂志,2014,(03):198.
　WU Zhi? yong,GUAN Rui? jin,CHEN Shi? quan,et al. Rotational atherectomy using small burr combined with drug-eluting stent implantation for the treatment of heavily calcified coronary lesions： analysis of clinical outcomes[J].journal interventional radiology,2014,(02):198.
[4]曾松柏,曾 山,张 梅,等.老年患者择期冠状动脉介入治疗中低剂量比伐卢定安全性观察[J].介入放射学杂志,2016,(03):250.
　ZENG Song- bai,ZENG Shan,ZHANG Mei,et al.The use of low- dose bivalirudin in elderly patients receiving elective percutaneous coronary intervention： observation of its safety[J].journal interventional radiology,2016,(02):250.
[5]刘洁银,鲍 骏,苏 衡,等.血管内超声指导药物涂层球囊介入治疗原位冠状动脉病变临床效果[J].介入放射学杂志,2023,32(10):960.
　LIU Jieyin,BAO Jun,SU Heng,et al.Intravascular ultrasound-guided interventional drug-coated balloon treatment for coronary arterial lesion in situ： evaluation of its efficacy[J].journal interventional radiology,2023,32(02):960.

备注/Memo

备注/Memo:
（收稿日期：２０１5-０7-08）
（本文编辑：俞瑞纲）
更新日期/Last Update: 2016-02-22